Search Login Register

Interleukin-1 (Interleukin 1) Summary

Description: A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation.

Also Known As: Interleukin 1; Lymphocyte Activating Factor; IL-1; Epidermal Cell Derived Thymocyte-Activating Factor; Interleukin I Show All >>

Networked: 9454 relevant articles (309 outcomes, 1050 trials/studies) for this Bio-Agent

Key Diseases for which Interleukin-1 is Relevant

  1. Inflammation : 35 outcomes 90 studies in 1401 results
  2. Rheumatoid Arthritis : 21 outcomes 37 studies in 420 results
  3. Infection : 20 outcomes 48 studies in 763 results
  4. Neoplasms (Cancer) : 19 outcomes 50 studies in 589 results
  5. Arthritis (Polyarthritis) : 14 outcomes 31 studies in 314 results
Show All >>

Drugs Related to Interleukin-1

  1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  2. Interleukin 1 Receptor Antagonist Protein (Anakinra)
  3. Interleukin-6 (Interleukin 6)
  4. Cytokines
  5. Interleukin-10 (Interleukin 10)
  6. Interleukin-1beta (Interleukin 1 beta)
  7. Interleukin-1 (Interleukin 1)
  8. Interleukins
  9. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
  10. Interleukin-1alpha (Interleukin 1 alpha)
Show All >>

Therapies Related to Interleukin-1

  1. Injections
  2. Transplantation (Transplant Recipients)
  3. Drug Therapy (Chemotherapy)
  4. Intra-Articular Injections
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.